Journal of Orthopedic Oncology
Open Access

Pediatric orthopedic; Musculoskeletal tumors; Sarcoma; Osteosarcoma

Introduction

Early detection and diagnosis are paramount in pediatric orthopedic oncology. Children’s rapidly growing bodies may mask the presence of a tumor until it reaches an advanced stage. Parents, caregivers, and healthcare providers must be vigilant in recognizing any persistent symptoms, such as localized pain, swelling, or a palpable mass. Advanced imaging techniques, including MRI and CT scans, play a crucial role in accurate tumor localization, staging, and assessing potential metastases. A timely and accurate diagnosis aids in devising an appropriate treatment plan and increasing the chances of a successful outcome [1]. The management of pediatric musculoskeletal tumors demands a multidisciplinary approach involving a team of specialists. Pediatric orthopedic oncologists, pediatric oncologists, radiation oncologists, pathologists, radiologists, and supportive care providers collaborate to formulate comprehensive treatment plans. This collaborative approach ensures that each patient’s unique medical and psychosocial needs are addressed effectively [2].

Treatment for pediatric musculoskeletal tumors typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgical interventions aim to remove the tumor while preserving as much healthy tissue and joint function as possible. Limb-sparing surgeries are often employed to maintain limb functionality and quality of life. These tumors may arise from the growth plates, leading to the potential for limb-length discrepancies or deformities as the child grows. The aggressive nature of certain tumors and their predilection for metastasis to other parts of the body requires prompt diagnosis and treatment. Advancements in chemotherapy protocols have significantly improved survival rates for certain pediatric bone tumors [3].

Targeted therapies, immunotherapies, and novel drug combinations are being explored in clinical trials to enhance treatment efficacy while minimizing side effects. Radiation therapy plays a role in local tumor control and may be used as a primary treatment for certain tumors or as an adjuvant therapy to surgery [4]. Precise radiation techniques help spare healthy surrounding tissues, minimizing long-term side effects. Caring for young patients with bone and soft tissue tumors goes beyond medical treatments. Psychosocial support and emotional well-being are integral aspects of managing pediatric oncology cases. Children and their families often face immense emotional challenges, and providing support throughout the treatment journey is crucial for their overall well-being. Continued research in pediatric orthopedic oncology is essential to further improve treatment outcomes and minimize the long-term effects of therapies. Clinical trials are ongoing to explore novel treatment strategies, targeted therapies, and immunotherapies, offering hope for improved survival rates and enhanced quality of life for young patients [5].

Discussion

Dealing with a diagnosis of cancer is emotionally challenging for young patients and their families. Pediatric orthopedic oncology teams place great emphasis on providing psychosocial support throughout the treatment journey. Child life specialists, social workers, and psychologists work alongside medical professionals to help patients cope with the emotional and social aspects of their diagnosis and treatment. Long-term follow-up is a crucial aspect of pediatric orthopedic oncology. Survivors of childhood cancer may face various late effects, such as orthopedic complications, cardiovascular issues, and secondary malignancies. Regular monitoring and surveillance are essential to identify and address any potential late effects and ensure survivors’ optimal health and well-being [6].

Pediatric bone and soft tissue tumors differ from those in adults in terms of tumor types, aggressiveness, and response to treatment. Common bone tumors in children include osteosarcoma, Ewing sarcoma, and chondrosarcoma, while soft tissue tumors like rhabdomyosarcoma and synovial sarcoma are also prevalent. Due to the rapid growth of bones and tissues in children, tumors can present unique challenges, often involving epiphyseal plates and growth centers. Early detection and accurate diagnosis are crucial for implementing appropriate treatment strategies. Pediatric orthopedic oncologists rely on a combination of advanced imaging modalities, including MRI, CT scans, and PET scans, to accurately diagnose and stage tumors in young patients. These imaging techniques help determine the extent of tumor involvement, identify any metastases, and facilitate precise surgical planning. Biopsies are carefully performed to confirm the tumor type, grade, and genetic characteristics, providing valuable information for tailored treatment [7].

The management of pediatric bone and soft tissue tumors demands a multidisciplinary team approach involving orthopedic surgeons, pediatric oncologists, radiation oncologists, radiologists, pathologists, physical therapists, and psychosocial support staff. This collaboration ensures comprehensive evaluation and personalized treatment plans that take into account the child’s unique needs and circumstances [8].

Limb-sparing surgeries are the gold standard for treating localized pediatric bone tumors while preserving limb function and growth. Innovative surgical techniques, including the use of expandable prostheses, 3D-printed implants, and biological reconstructions, have revolutionized limb-salvage procedures. The goal is to remove the tumor while avoiding damage to growth plates, enabling the child’s limb to continue growing alongside their healthy peers [9].

Chemotherapy plays a central role in the treatment of pediatric bone and soft tissue tumors. It is often administered before and after surgery to shrink the tumor and prevent the spread of cancer cells. In recent years, targeted therapies have shown promise in pediatric oncology by specifically targeting molecules involved in tumor growth, reducing side effects, and improving treatment efficacy. Radiation therapy is selectively used in pediatric orthopedic oncology, especially for tumors that are not amenable to surgical resection or as an adjuvant treatment after surgery. The unique vulnerability of growing tissues in children requires careful planning to minimize long-term effects on bone development and growth [10].

Conclusion

Pediatric orthopedic oncology represents a unique and challenging area of medicine, requiring a compassionate, multidisciplinary approach. Through advances in imaging, surgical techniques, chemotherapy, targeted therapies, and psychosocial support, the field has made significant strides in managing tumors in young patients. Despite the complexities involved, the dedication and expertise of healthcare providers continue to offer hope and optimism to these young warriors and their families, ensuring that they receive the best possible care and support throughout their journey to recovery and beyond. Pediatric orthopedic oncology represents a delicate balance between aggressive tumor management and preserving the functional outcomes and quality of life of young patients. Early detection, multidisciplinary collaboration, and advancements in treatment modalities have significantly improved the Pediatric orthopedic oncology is a highly specialized branch of medicine dedicated to the diagnosis, treatment, and management of bone and soft tissue tumors in children and adolescents. Managing tumors in young patients requires a delicate balance between providing curative therapies and preserving their physical and emotional wellbeing.

This article delves into the unique challenges faced by healthcare providers in pediatric orthopedic oncology and highlights the multidisciplinary approach and advancements that have significantly improved outcomes for these young warriors.

1. Kaim AH, Hugli R, Bonél HM, Jundt G (2002) Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation. Skeletal Radiol 31:88–95.

Indexed at, Google Scholar, Crossref

2. Nathalie L,  Sun J, Gondara L, Diocee R , Speers  C et al. (2020) Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis. J Canc Res Clin Oncol 146: 529-536.

Indexed at, Google Scholar, Crossref

3. Cranshaw I, Gikas P, Fisher C (2009) Clinical outcomes of extra- thoracic solitary fibrous tumours. Eur J Surg Oncol 35: 994-998.

Indexed at, Google Scholar, CrossRef

4. Demicco EG, Park MS, Araujo DM (2012) Solitary fibrous tumor: a clinic pathological study of 110 cases and proposed risk assess- ment model. Mod Pathol 25: 1298-1306

Indexed at, Google Scholar, CrossRef

5. Kaim AH, Hugli R, Bonél HM, Jundt G (2002) Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation. Skeletal Radiol 31:88–95.

Indexed at, Google Scholar, Crossref

6. Little PJ, Drennon KD, Tannock LR (2008) Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP. Arch Physiol Biochem 114: 120-126.

Indexed at, Google Scholar, CrossRef

7. Poggio F, Bruzzone  M, Ceppi M, Ponde N F, Valle G et al. (2018) Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol 29: 1497-1508.

Indexed at, Google Scholar, Crossref

8. Nathalie L,  Sun J, Gondara L, Diocee R , Speers  C et al. (2020) Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis. J Canc Res Clin Oncol 146: 529-536.

Indexed at, Google Scholar, Crossref

9. Choi H, Charnsangavej C, Faria SC (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25: 1753-1759.

Indexed at, Google Scholar, CrossRef

10. Hangaard H, Gögenur M, Tvilling M, Gögenur I (2018) The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: a systematic review. Eur J Surg Oncol 44: 1479-1485.

Indexed at, Google Scholar, CrossRef